The combined treatment of bone marrow-derived MSCs and resveratrol in EAE MS model was shown to suppress proinflammatory cytokines IFN-γ and TNF-α and increase anti-inflammatory cytokines IL-4 and IL-10, thus alleviating EAE symptoms [408]. This evidence concerns the gene IL4 and myeloid sarcoma.